EYPT EyePoint Pharmaceuticals, Inc.
Healthcare$13.35+3.25%ClosedMarket Cap: $1.12B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$37.50
Target (Median)
$37.50
Target Range
$36.00 - $39.00
Upside from current price: 180.9%
Rating Distribution
3 Strong Buy10 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-07 | RBC Capital | maintain | Outperform | Outperform |
| 2026-03-09 | Citigroup | maintain | Buy | Buy |
| 2026-03-05 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-04 | Chardan Capital | maintain | Buy | Buy |
| 2025-11-06 | RBC Capital | maintain | Outperform | Outperform |
| 2025-08-07 | Chardan Capital | maintain | Buy | Buy |
| 2025-08-06 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-05-29 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.81 | $47.7M | 8 |
| Sun Dec 31 | $-1.36 | $284.9M | 7 |
| Mon Dec 31 | $0.50 | $564.4M | 2 |
| Tue Dec 31 | $2.44 | $845.8M | 5 |